Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Alterations in proteome and proteostasis networks during replicative senescence

ABSTRACT: The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the total proteome, the ubiquitin-modified proteome, the phospho-proteome and in protein solubility during replicative senescence in human IMR90 fibroblasts. This accession contains data regarding alterations on protein solubility, in control and ATP-supplemented conditions.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Fibroblast Of Lung

SUBMITTER: Petra Beli

LAB HEAD: Petra Beli

PROVIDER: PXD069123 | Pride | 2026-07-16

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20241103_AST1_PBE_NS_GC1_insoluble_P1.raw	Raw
	20241103_AST1_PBE_NS_GC1_insoluble_P1_ATP.raw	Raw
	20241103_AST1_PBE_NS_GC1_insoluble_P2.raw	Raw
	20241103_AST1_PBE_NS_GC1_insoluble_P2_ATP.raw	Raw
	20241103_AST1_PBE_NS_GC1_insoluble_P3.raw	Raw

Items per page:

1 - 5 of 48

Similar Datasets

Alterations in proteome and proteostasis networks during replicative senescence

Project description:The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the proteome and its post translational modifications, as well as protein solubility, during replicative senescence in human IMR90 fibroblasts. This accession contains data regarding alterations on the ubiquitin-modified proteome, in control and Bortezomib-treated conditions.

2026-07-16 | PXD077923 | Pride

Alterations in proteome and proteostasis networks during replicative senescence

Project description:The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the proteome and its post translational modifications, as well as protein solubility, during replicative senescence in human IMR90 fibroblasts. This accession contains data regarding alterations on the SUMO2/3-modified proteome during replicative senescence.

2026-07-16 | PXD077854 | Pride

Alterations in proteome and proteostasis networks during replicative senescence

Project description:The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the proteome and its post translational modifications, as well as protein solubility, during replicative senescence in human IMR90 fibroblasts. This accession contains the proteome data of proliferative and senescent cells, with a total of 200 000 cells were analyzed per condition.

2026-07-16 | PXD077797 | Pride

Alterations in proteome and proteostasis networks during replicative senescence

Project description:The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the total proteome, the ubiquitin-modified proteome, the phospho-proteome and in protein solubility during replicative senescence in human IMR90 fibroblasts. This accession contains the data related with the exposure of prolifertive cells to different "stressors", as well as the autophagy flux files.

2026-07-16 | PXD069129 | Pride

Alterations in proteome and proteostasis networks during replicative senescence

Project description:The accumulation of senescent cells constitutes a pivotal hallmark of tissue ageing, contributing to disruption of tissue homeostasis and thus, to the development of several aging-related diseases. Despite this, our knowledge about the molecular, spatial and temporal changes that drive aging on a cellular basis remains poorly understood. To elucidate these mechanisms, we employed mass spectrometry-based proteomics to determine changes in the total proteome, the ubiquitin-modified proteome, the phospho-proteome and in protein solubility during replicative senescence in human IMR90 fibroblasts. This accession contains data of the ubiquitin-modified proteome.

2026-07-16 | PXD067585 | Pride

Supercharging-Enhanced nDIA-MS Enables Global Profiling of Drug-Induced Proteome Solubility Shifts (solubility proteomics)

Project description:Mass spectrometry (MS)-based proteomics has become indispensable for high-throughput quantitation of protein expression. However, protein function is regulated by a variety of factors beyond abundance alone. Here, we optimized narrow-window, data-independent ac-quisition (nDIA) MS with 3% DMSO as a supercharging co-solvent, boosting signal intensity by up to 56% and enabling identification of ~9,600 proteins from 1 µg of HeLa digest with a 15 min gradient. Using this methodology, we quantified solubility and abundance changes in 8,694 pro-teins across three cell lines following short-term treatment with the proteasome inhibitor MG132 and the SUMO-activating enzyme inhibitor ML-792. MG132 affected the solubility of 1,723 pro-teins and the abundance of 374, and ML-792 impacted 1,294 and 288, respectively. The drugs elicited distinct and sometimes opposing solubility shifts; For instance, MG132 insolubilized HSF1, ML-792 solubilized SP100 and insolubilized PLOR3G, and SMAD2 showed opposite responses to those two treatments. These results reveal widespread, drug-induced remodeling of the pro-tein solubility landscape and establish solubility profiling by nDIA-MS as a robust and broadly ap-plicable platform for uncovering protein state transitions and cellular responses to perturbation.

2026-01-12 | PXD064185 | Pride

Supercharging-Enhanced nDIA-MS Enables Global Profiling of Drug-Induced Proteome Solubility Shifts (co-solvent)

Project description:Mass spectrometry (MS)-based proteomics has become indispensable for high-throughput quantitation of protein expression. However, protein function is regulated by a vari-ety of factors beyond abundance alone. Here, we optimized narrow-window, data-independent acquisition (nDIA) MS with 3% DMSO as a supercharging co-solvent, boosting signal intensity by up to 56% and enabling identification of ~9,600 proteins from 1 µg of HeLa digest with a 15 min gradient. Using this methodology, we quantified solubility and abundance changes in 8,694 proteins across three cell lines following short-term treatment with the proteasome in-hibitor MG132 and the SUMO-activating enzyme inhibitor ML-792. MG132 affected the solubil-ity of 1,723 proteins and the abundance of 374, and ML-792 impacted 1,294 and 288, respec-tively. The drugs elicited distinct and sometimes opposing solubility shifts; For instance, MG132 insolubilized HSF1, ML-792 solubilized SP100 and insolubilized PLOR3G, and SMAD2 showed opposite responses to those two treatments. These results reveal wide-spread, drug-induced remodeling of the protein solubility landscape and establish solubility profiling by nDIA-MS as a robust and broadly applicable platform for uncovering protein state transitions and cellular responses to perturbation.

2026-01-11 | PXD064180 | Pride

Global Matrisome changes in the obese lung are linked to fibroblastic stroma and premature aging

Project description:Obesity is associated with an increased risk of lung disorders, yet its effects on lung tissue structure and the microenvironment remain incompletely understood. Using a multiomics strategy combining tissue proteomics, lipidomics, solubility profiling, single-cell transcriptomics, and functional assays, we investigated how obesity affects lung composition and fibroblast behavior. Our data indicate that obesity induces remodeling of the extracellular matrix, including changes in elastic fiber-associated proteins, and is accompanied by reduced levels of protease inhibitors in lung tissue and BALF. Stromal fibroblasts accumulated lipids and exhibited increased contractility, matrisome alterations, and transcriptional hallmarks of aging. Comparison of obese and aging lungs revealed overlapping solubility changes in structural matrix proteins. These findings suggest that obesity may induce premature aging of fibroblasts and consequent remodeling of the lung microenvironment, with potential implications for tissue compliance and repair responses.

2025-08-21 | PXD064724 | Pride

Proteomic investigation of thyroid aging and pathogenesis reveals health and disease in thyroid cancers.

Project description:Understanding thyroid aging is essential for deciphering its physiological and pathological alterations, yet the causal relationship between aging and thyroid disease remains poorly characterized. We conducted a comprehensive proteomic analysis of 6109 thyroid tissues across ages 8-87 from 22 clinical centers (retrospective and prospective cohorts). Using a machine learning-based biological aging clock, we quantified accelerated aging phenotypes in pathological tissues, including benign and malignant nodules. We identified linear and non-linear age-associated proteins and pathways related to metabolism, immune response, and extracellular matrix organization remodeling, with critical transitions observed during the third, sixth, and eighth decades. Cross-species analysis of mouse and monkey tissues uncovered conserved aging markers. Intervention studies suggested that low-protein diets delay thyroid aging in mice, and therapeutic drug screening identified potential anti-tumor candidates. This study establishes the first organ-specific thyroid aging clock, linking tumorigenesis to accelerated aging, and proposing dietary interventions for thyroid longevity.

2025-11-04 | PXD061183 | Pride

Protein solubility changes in mouse neocortex during aging.

Project description:Protein solubility changes in mouse neocortex during aging.

2026-02-23 | PXD057311 | Pride